Sleep disturbances and frailty status in older community-dwelling men
- PMID: 19793160
- PMCID: PMC3024909
- DOI: 10.1111/j.1532-5415.2009.02490.x
Sleep disturbances and frailty status in older community-dwelling men
Abstract
Objectives: To test the hypothesis that sleep disturbances are independently associated with frailty status in older men.
Design: Cross-sectional analysis of prospective cohort study.
Setting: Six U.S. centers.
Participants: Three thousand one hundred thirty-three men aged 67 and older.
Measurements: Self-reported sleep parameters (questionnaire); objective parameters of sleep-wake patterns (actigraphy data collected for an average of 5.2 nights); and objective parameters of sleep-disordered breathing, nocturnal hypoxemia, and periodic leg movements with arousals (PLMAs) (in-home overnight polysomnography). Frailty status was classified as robust, intermediate stage, or frail using criteria similar to those used in the Cardiovascular Health Study frailty index.
Results: The prevalence of sleep disturbances, including poor sleep quality, excessive daytime sleepiness, short sleep duration, lower sleep efficiency, prolonged sleep latency, sleep fragmentation (greater nighttime wakefulness and frequent, long wake episodes), sleep-disordered breathing, nocturnal hypoxemia, and frequent PLMAs, was lowest in robust men, intermediate in men in the intermediate-stage group, and highest in frail men (P-for-trend < or =.002 for all sleep parameters). After adjusting for multiple potential confounders, self-reported poor sleep quality (Pittsburgh Sleep Quality Index > 5, multivariable odds ratio (MOR)=1.28, 95% confidence interval (CI)=1.09-1.50), sleep efficiency less than 70% (MOR=1.37, 95% CI=1.12-1.67), sleep latency of 60 minutes or longer (MOR=1.42, 95% CI=1.10-1.82), and sleep-disordered breathing (respiratory disturbance index > or =15, MOR=1.38, 95% CI=1.15-1.65) were each independently associated with higher odds of greater frailty status.
Conclusion: Sleep disturbances, including poor self-reported sleep quality, lower sleep efficiency, prolonged sleep latency, and sleep-disordered breathing, are independently associated with greater evidence of frailty.
Conflict of interest statement
Drs. Ensrud, Redline, and Ancoli-Israel have received grant support from the NIH (and supporting agencies) as listed under Funding Sources on the title page.
Dr. Ancoli-Israel is on the scientific advisory board or has consulted for Arena, Cephalon Inc., Ferring Pharmaceuticals Inc., Orphagen Pharmaceuticals, Pfizer, Respironics, Sanofi-Aventis, Sepracor Inc., Schering-Plough, Somaxon, and Takeda Pharmaceuticals North America Inc.
Dr. Barrett-Connor has received grant support from the NIH (and supporting agencies) as listed under Funding Sources on the title page
Dr. Stone has received grant support from the NIH (and supporting agencies) as listed under Funding Sources on the title page
References
-
- Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: Results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999;22 (Suppl 2):S347–S353. - PubMed
-
- Foley D, Ancoli-Israel S, Britz P, et al. Sleep disturbances and chronic disease in older adults: Results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 2004;56:497–502. - PubMed
-
- Foley DJ, Monjan AA, Brown SL, et al. Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep. 1995;18:425–432. - PubMed
-
- Newman AB, Enright PL, Manolio TA, et al. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: The Cardiovascular Health Study. J Am Geriatr Soc. 1997;45:1–7. - PubMed
-
- Ensrud KE, Blackwell TL, Ancoli-Israel S, et al. Use of selective serotonin reuptake inhibitors and sleep disturbances in community-dwelling older women. J Am Geriatr Soc. 2006;54:1508–1515. - PubMed
Publication types
MeSH terms
Grants and funding
- U01 AR45632/AR/NIAMS NIH HHS/United States
- R01 HL070848/HL/NHLBI NIH HHS/United States
- R01 HL071194/HL/NHLBI NIH HHS/United States
- R01 HL070847/HL/NHLBI NIH HHS/United States
- R01HL070848/HL/NHLBI NIH HHS/United States
- U01 AR45647/AR/NIAMS NIH HHS/United States
- R01 HL070842/HL/NHLBI NIH HHS/United States
- U01 AR45614/AR/NIAMS NIH HHS/United States
- U01 AR045654/AR/NIAMS NIH HHS/United States
- U01-AG027810/AG/NIA NIH HHS/United States
- U01 AR45583/AR/NIAMS NIH HHS/United States
- R01 HL070839/HL/NHLBI NIH HHS/United States
- R01 HL070837/HL/NHLBI NIH HHS/United States
- R01 AG008415/AG/NIA NIH HHS/United States
- R01HL071194/HL/NHLBI NIH HHS/United States
- U01 AR045614/AR/NIAMS NIH HHS/United States
- U01 AR45654/AR/NIAMS NIH HHS/United States
- U01 AR045583/AR/NIAMS NIH HHS/United States
- R01 HL070841/HL/NHLBI NIH HHS/United States
- U01 AG042140/AG/NIA NIH HHS/United States
- R01 HL070838/HL/NHLBI NIH HHS/United States
- U01 AR045647/AR/NIAMS NIH HHS/United States
- U01 AR45580/AR/NIAMS NIH HHS/United States
- U01 AG027810/AG/NIA NIH HHS/United States
- AG08415/AG/NIA NIH HHS/United States
- UL1 RR024140/RR/NCRR NIH HHS/United States
- U01 AR045580/AR/NIAMS NIH HHS/United States
- U01 AG18197/AG/NIA NIH HHS/United States
- U01 AG018197/AG/NIA NIH HHS/United States
- U01 AR066160/AR/NIAMS NIH HHS/United States
- U01 AR045632/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
